Robert Clark
Directeur/Membre du Conseil chez INCANNEX HEALTHCARE INC.
Fortune : 283 000 $ au 31/05/2024
Postes actifs de Robert Clark
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INCANNEX HEALTHCARE INC. | Directeur/Membre du Conseil | 17/08/2022 | - |
| Independent Dir/Board Member | 17/08/2022 | - | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Conseiller Juridique Général | 01/01/2012 | - |
Historique de carrière de Robert Clark
Anciens postes connus de Robert Clark
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/01/1992 | 01/01/2021 |
Formation de Robert Clark
| New York Medical College | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| INCANNEX HEALTHCARE INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Bourse
- Insiders
- Robert Clark
- Expérience
